Greenland Mines Ltd SEC filings GRML
Greenland Mines Ltd has 268 filings in SEC EDGAR's recent list, going back to Jan 31, 2022. Its latest annual report, Form 10-K, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 17, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 2, 2026 | — |
| 4 | Insider transaction | Aug 25, 2026 | Aug 25, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 22, 2026 |
| 4 | Insider transaction | Jul 20, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jul 17, 2026 | Jul 16, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 25, 2026 |
| 144 | Notice of proposed sale | Jun 24, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 13, 2026 | — |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Sep 29, 2025 | Sep 25, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 25, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 8, 2025 | Aug 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 2, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 2, 2025 | — |
| 4 | Insider transaction | Jul 2, 2024 | Jun 28, 2024 |
| 3 | Initial insider ownership | Jul 1, 2024 | Jun 21, 2024 |
| SC 13G | Ownership over 5% (passive) | Jun 27, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 22, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 6, 2023 | — |
| 4 | Insider transaction | Apr 11, 2022 | Apr 7, 2022 |
| SC 13G | Ownership over 5% (passive) | Apr 7, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Apr 7, 2022 | — |
| 4 | Insider transaction | Apr 4, 2022 | Apr 4, 2022 |
| SC 13G | Ownership over 5% (passive) | Apr 1, 2022 | — |
| 3 | Initial insider ownership | Mar 30, 2022 | Mar 30, 2022 |
| 3 | Initial insider ownership | Mar 30, 2022 | Mar 30, 2022 |
| 3 | Initial insider ownership | Mar 30, 2022 | Mar 30, 2022 |
| 3 | Initial insider ownership | Mar 30, 2022 | Mar 30, 2022 |
| 3 | Initial insider ownership | Mar 30, 2022 | Mar 30, 2022 |
| 3 | Initial insider ownership | Mar 30, 2022 | Mar 30, 2022 |
Showing 49 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GRML (Nasdaq), GRMLW (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Omaha, NE
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1907223
- Former names
- Klotho Neurosciences, Inc. (until Mar 10, 2026); ANEW Medical, Inc. (until Sep 18, 2024); Redwoods Acquisition Corp. (until Jun 21, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.